CD133/CD166/Ki-67 triple immunofluorescence assessment for putative cancer stem cells in colon carcinoma

Keyphrases

• Immunofluorescence 100%
• Colon Adenocarcinoma 100%
• Ki-67 100%
• Cancer Stem Cells 100%
• CD133 100%
• CD166 100%
• Colocalization 33%
• Tumor 22%
• Colon Cancer 22%
• High-grade Dysplasia 22%
• Higher Coefficients 22%
• AIMS™ 11%
• Prognostic Marker 11%
• Colorectal Cancer 11%
• Malignancy 11%
• Treatment Failure 11%
• Expression Level 11%
• Cell Membrane 11%
• Cancer Mortality 11%
• Metastasis 11%
• Co-expression 11%
• Early Events 11%
• Cancer Causes 11%
• Most Common Cause 11%
• Tumoral 11%
• All Cancer 11%
• Fluorescence Immunoassay 11%
• Immunoexpression 11%
• Multidrug-resistant 11%
• Cytoplasmic Patterns 11%
• Well-differentiated 11%
• Dysplastic Lesions 11%
• Colon Cancer Stem Cells 11%
• Colon Tumorigenesis 11%
• Multiple Fluorescence 11%

Medicine and Dentistry

• Immunofluorescence 100%
• Colon Carcinoma 100%
• Colon Cancer 100%
• Cancer Stem Cell 100%
• Neoplasm 66%
• Dysplasia 66%
• Colon 33%
• Malignant Neoplasm 33%
• Metastatic Carcinoma 33%
• Cancer 33%
• Immunohistochemistry 33%
• Recurrent Disease 33%
• Colorectal Cancer 33%
• Cell Membrane 33%
• Cancer Mortality 33%
• Carcinogenesis 33%
• Colon Adenocarcinoma 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Colon Cancer 100%
• Colon Carcinoma 100%
• Neoplasm 66%
• Dysplasia 66%
• Recurrent Disease 33%
• Colorectal Cancer 33%
• Cancer Mortality 33%
• Carcinogenesis 33%
• Colon Adenocarcinoma 33%